drugset / Trial / NCT04906590
PPMI Tau PET Imaging
Phase 2
Completed
23 enrolled
Michael J. Fox Foundation for Parkinson's Research
Institute for Neurodegenerative Disorders · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The Assessment of Brain Tau Burden in Participants with Parkinson's Disease in the PPMI Study (PPMI Tau PET Imaging) will evaluate if \[18F\] PI-2620 facilitates better understanding of Tau deposition in the brain in Parkinson's disease (PD).
Timeline
- Start
- 2021-08-30
- Primary completion
- 2023-01-30
- Completion
- 2023-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PI-2620 | Diagnostic / imaging agent | — | — |